These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 34253084)

  • 1. Heterogeneity of Access to Diabetes Technology Depending on Area Deprivation and Demographics Between 2016 and 2019 in Germany.
    Auzanneau M; Rosenbauer J; Maier W; von Sengbusch S; Hamann J; Kapellen T; Freckmann G; Schmidt S; Lilienthal E; Holl RW
    J Diabetes Sci Technol; 2021 Sep; 15(5):1059-1068. PubMed ID: 34253084
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal Trends and Contemporary Use of Insulin Pump Therapy and Glucose Monitoring Among Children, Adolescents, and Adults With Type 1 Diabetes Between 1995 and 2017.
    van den Boom L; Karges B; Auzanneau M; Rami-Merhar B; Lilienthal E; von Sengbusch S; Datz N; Schröder C; Kapellen T; Laimer M; Schmid SM; Müller H; Wolf J; Holl RW
    Diabetes Care; 2019 Nov; 42(11):2050-2056. PubMed ID: 31488568
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Insulin pump therapy and continuous glucose monitoring].
    Schütz-Fuhrmann I; Rami-Merhar B; Fröhlich-Reiterer E; Hofer SE; Tauschmann M; Mader JK; Resl M; Kautzky-Willer A; Winhofer-Stöckl Y; Laimer M; Zlamal-Fortunat S; Weitgasser R
    Wien Klin Wochenschr; 2023 Jan; 135(Suppl 1):53-61. PubMed ID: 37101025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Area Deprivation and Regional Disparities in Treatment and Outcome Quality of 29,284 Pediatric Patients With Type 1 Diabetes in Germany: A Cross-sectional Multicenter DPV Analysis.
    Auzanneau M; Lanzinger S; Bohn B; Kroschwald P; Kuhnle-Krahl U; Holterhus PM; Placzek K; Hamann J; Bachran R; Rosenbauer J; Maier W;
    Diabetes Care; 2018 Dec; 41(12):2517-2525. PubMed ID: 30327359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy - Pump vs multiple daily injections, a secondary analysis of an observational cohort study.
    Kjölhede K; Berntorp K; Kristensen K; Katsarou A; Shaat N; Wiberg N; Knop FK; Kristensen L; Dotevall A; Elfvin A; Sandgren U; Sengpiel V; Englund-Ögge L
    Acta Obstet Gynecol Scand; 2021 May; 100(5):927-933. PubMed ID: 33176006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Early versus delayed insulin pump therapy in children with newly diagnosed type 1 diabetes: results from the multicentre, prospective diabetes follow-up DPV registry.
    Kamrath C; Tittel SR; Kapellen TM; von dem Berge T; Heidtmann B; Nagl K; Menzel U; Pötzsch S; Konrad K; Holl RW
    Lancet Child Adolesc Health; 2021 Jan; 5(1):17-25. PubMed ID: 33253630
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Expert Opinion on Advanced Insulin Pump Use in Youth with Type 1 Diabetes.
    Bode BW; Kaufman FR; Vint N
    Diabetes Technol Ther; 2017 Mar; 19(3):145-154. PubMed ID: 28135116
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment satisfaction and quality of life for an integrated continuous glucose monitoring/insulin pump system compared to self-monitoring plus an insulin pump.
    Rubin RR; Peyrot M
    J Diabetes Sci Technol; 2009 Nov; 3(6):1402-10. PubMed ID: 20144395
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial.
    Beck RW; Riddlesworth TD; Ruedy KJ; Kollman C; Ahmann AJ; Bergenstal RM; Bhargava A; Bode BW; Haller S; Kruger DF; McGill JB; Polonsky W; Price D; Toschi E;
    Lancet Diabetes Endocrinol; 2017 Sep; 5(9):700-708. PubMed ID: 28711468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differences in Use of Glucose Rate of Change (ROC) Arrows to Adjust Insulin Therapy Among Individuals With Type 1 and Type 2 Diabetes Who Use Continuous Glucose Monitoring (CGM).
    Pettus J; Edelman SV
    J Diabetes Sci Technol; 2016 Sep; 10(5):1087-93. PubMed ID: 27044518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lessons learned from a pilot RCT of simultaneous versus delayed initiation of continuous glucose monitoring in children and adolescents with type 1 diabetes starting insulin pump therapy.
    Olivier P; Lawson ML; Huot C; Richardson C; Nakhla M; Romain J
    J Diabetes Sci Technol; 2014 May; 8(3):523-8. PubMed ID: 24876616
    [TBL] [Abstract][Full Text] [Related]  

  • 12. HypoDE: Research Design and Methods of a Randomized Controlled Study Evaluating the Impact of Real-Time CGM Usage on the Frequency of CGM Glucose Values <55 mg/dl in Patients With Type 1 Diabetes and Problematic Hypoglycemia Treated With Multiple Daily Injections.
    Heinemann L; Deiss D; Hermanns N; Graham C; Kaltheuner M; Liebl A; Price D
    J Diabetes Sci Technol; 2015 May; 9(3):651-62. PubMed ID: 25759183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lower frequency of insulin pump treatment in children and adolescents of Turkish background with type 1 diabetes: analysis of 21,497 patients in Germany.
    Icks A; Razum O; Rosenbauer J; Bächle C; Hungele A; Mönkemöller K; Müller-Godeffroy E; Heidtmann B; Kapellen T; Scheuing N; Holl RW
    Diabetes Technol Ther; 2012 Dec; 14(12):1105-9. PubMed ID: 23216338
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Insulin Pump and Continuous Glucose Monitor Initiation in Hospitalized Patients with Type 2 Diabetes Mellitus.
    Levitt DL; Spanakis EK; Ryan KA; Silver KD
    Diabetes Technol Ther; 2018 Jan; 20(1):32-38. PubMed ID: 29293367
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Day and night glycaemic control with a bionic pancreas versus conventional insulin pump therapy in preadolescent children with type 1 diabetes: a randomised crossover trial.
    Russell SJ; Hillard MA; Balliro C; Magyar KL; Selagamsetty R; Sinha M; Grennan K; Mondesir D; Ekhlaspour L; Zheng H; Damiano ER; El-Khatib FH
    Lancet Diabetes Endocrinol; 2016 Mar; 4(3):233-243. PubMed ID: 26850709
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of Different Treatment Modalities for Type 1 Diabetes, Including Sensor-Augmented Insulin Regimens, in 52 Weeks of Follow-Up: A COMISAIR Study.
    Šoupal J; Petruželková L; Flekač M; Pelcl T; Matoulek M; Daňková M; Škrha J; Svačina Š; Prázný M
    Diabetes Technol Ther; 2016 Sep; 18(9):532-8. PubMed ID: 27482825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of technology on glycaemic control in type 2 diabetes: A meta-analysis of randomized trials on continuous glucose monitoring and continuous subcutaneous insulin infusion.
    Dicembrini I; Mannucci E; Monami M; Pala L
    Diabetes Obes Metab; 2019 Dec; 21(12):2619-2625. PubMed ID: 31368658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diabetes technology and treatments in the paediatric age group.
    Shalitin S; Peter Chase H
    Int J Clin Pract Suppl; 2011 Feb; (170):76-82. PubMed ID: 21323816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lag Time Remains with Newer Real-Time Continuous Glucose Monitoring Technology During Aerobic Exercise in Adults Living with Type 1 Diabetes.
    Zaharieva DP; Turksoy K; McGaugh SM; Pooni R; Vienneau T; Ly T; Riddell MC
    Diabetes Technol Ther; 2019 Jun; 21(6):313-321. PubMed ID: 31059282
    [No Abstract]   [Full Text] [Related]  

  • 20. A Mobile Application Guiding Patients With Type 1 Diabetes Using Sensor-Augmented Insulin Pump Therapy.
    Esvant A; Lefebvre MA; Campillo-Gimenez B; Lannes M; Delamarre D; Guilhem I; Poirier JY
    J Diabetes Sci Technol; 2016 Jul; 10(4):985-6. PubMed ID: 26902791
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.